BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 6409444)

  • 21. Inhibitory effect of phenolic compounds on aflatoxin B1 metabolism and induced mutagenesis.
    San RH; Chan RI
    Mutat Res; 1987 Apr; 177(2):229-39. PubMed ID: 3104775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
    Robertson IG; Zeiger E; Goldstein JA
    Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
    Kamataki T; Maeda K; Yamazoe Y; Matsuda N; Ishii K; Kato R
    Mol Pharmacol; 1983 Jul; 24(1):146-55. PubMed ID: 6408394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Aflatoxin B1-specific cytochrome P-450 isozyme (P-450-AFB) inducible by 3-methylcholanthrene in golden hamsters.
    Fukuhara M; Mizokami K; Sakaguchi M; Niimura Y; Kato K; Inouye S; Takanaka A
    Biochem Pharmacol; 1990 Feb; 39(3):463-9. PubMed ID: 2106321
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
    Yourtee DM; Kirk-Yourtee CL
    Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cytochrome P3-450 cDNA encodes aflatoxin B1-4-hydroxylase.
    Faletto MB; Koser PL; Battula N; Townsend GK; Maccubbin AE; Gelboin HV; Gurtoo HL
    J Biol Chem; 1988 Sep; 263(25):12187-9. PubMed ID: 3137222
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of three forms of cytochrome P-450 inducible by 3-methylcholanthrene in Golden hamster livers with special reference to aflatoxin B1 activation.
    Fukuhara M; Nohmi T; Mizokami K; Sunouchi M; Ishidate M; Takanaka A
    J Biochem; 1989 Aug; 106(2):253-8. PubMed ID: 2509440
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of a form of cytochrome P-450 with high specificity for aflatoxin B1 from 3-methylcholanthrene-treated hamster liver.
    Mizokami K; Nohmi T; Fukuhara M; Takanaka A; Omori Y
    Biochem Biophys Res Commun; 1986 Sep; 139(2):466-72. PubMed ID: 3094515
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purified form of cytochrome P-450 from rainbow trout with high activity toward conversion of aflatoxin B1 to aflatoxin B1-2,3-epoxide.
    Williams DE; Buhler DR
    Cancer Res; 1983 Oct; 43(10):4752-6. PubMed ID: 6411332
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Indole-3-carbinol and beta-naphthoflavone induction of aflatoxin B1 metabolism and cytochromes P-450 associated with bioactivation and detoxication of aflatoxin B1 in the rat.
    Stresser DM; Bailey GS; Williams DE
    Drug Metab Dispos; 1994; 22(3):383-91. PubMed ID: 8070314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism, covalent binding, and mutagenicity of aflatoxin B1 by liver extracts from rats of various ages.
    Jayaraj A; Hardwick JP; Diller TW; Richardson AG
    J Natl Cancer Inst; 1985 Jan; 74(1):95-103. PubMed ID: 3918213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specificity of rabbit pulmonary cytochrome P-450 isozymes in the activation of several aromatic amines and aflatoxin B1.
    Robertson LG; Philpot RM; Zeiger E; Wolf CR
    Mol Pharmacol; 1981 Nov; 20(3):662-8. PubMed ID: 6799775
    [No Abstract]   [Full Text] [Related]  

  • 33. Metabolic activation of emodin in the reconstituted cytochrome P-450 system of the hepatic microsomes of rats.
    Tanaka H; Morooka N; Haraikawa K; Ueno Y
    Mutat Res; 1987 Feb; 176(2):165-70. PubMed ID: 3100945
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic activation of aflatoxin B1 and 2-amino-3-methylimidazo[4,5-f]-quinoline by human adult and fetal livers.
    Kitada M; Taneda M; Ohta K; Nagashima K; Itahashi K; Kamataki T
    Cancer Res; 1990 May; 50(9):2641-5. PubMed ID: 2109655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The in vitro metabolism of aflatoxin B1 catalyzed by hepatic microsomes isolated from control or 3-methylcholanthrene-stimulated rats and quail.
    Neal GE; Judah DJ; Green JA
    Toxicol Appl Pharmacol; 1986 Mar; 82(3):454-60. PubMed ID: 3082038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dietary administration of 2(3)-t-butyl-4-hydroxyanisole elevates mouse liver microsome-mediated DNA binding and mutagenicity of aflatoxin B1.
    Rahimtula AD; Martin M
    Chem Biol Interact; 1984 Feb; 48(2):207-20. PubMed ID: 6421497
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activation and inactivation of a variety of mutagenic compounds by the reconstituted system containing highly purified preparations of cytochrome P-450 from rat liver.
    Kawano S; Kamataki T; Maeda K; Kato R; Nakao T; Mizoguchi I
    Fundam Appl Toxicol; 1985 Jun; 5(3):487-98. PubMed ID: 3924696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of extra-hepatic Walker sarcoma 256 on the synthesis and degradation of liver cytochromes P-450 and b5.
    Raw I
    Braz J Med Biol Res; 1983 Dec; 16(4):291-5. PubMed ID: 6424747
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of monooxygenase activity in elasmobranchs and mammals: activation of the model pro-carcinogen aflatoxin B1 by liver preparations of calf, nurse shark and clearnose skate.
    Bodine AB; Luer CA; Gangjee S
    Comp Biochem Physiol C Comp Pharmacol Toxicol; 1985; 82(2):255-7. PubMed ID: 2866897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.